Shots:
- Agilent Technologies has entered into a definitive agreement to acquire Biocare Medical from investor groups led by Excellere Partners & GHO Capital Partners
- As per the deal, Agilent will acquire Biocare in an all-cash transaction valued at $950M, with closing anticipated by Q4’26, after which Biocare will become a part of the Agilent Life Sciences & Diagnostics Markets Group
- Acquisition will strengthen Agilent’s pathology & IVD antibody portfolio, expand its reach in clinical & research pathology labs, as well as accelerate innovation & menu development
Ref: Businesswire | Image: Biocare Medical | Press Release
Related News: Servier to Acquire Day One Biopharmaceuticals for ~$2.5B
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
